API
MRNA icon

Advisor Partners II’s Moderna MRNA Stock Holding History

Advisor Partners II’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$631K Sell
6,111
-930
-13% -$104K 0.03% 625
2023
Q2 		$855K Sell
7,041
-367
-5% -$49K 0.04% 436
2023
Q1 		$1.14M Sell
7,408
-3,125
-30% -$516K 0.06% 320
2022
Q4 		$1.89M Buy
10,533
+4,746
+82% +$776K 0.12% 192
2022
Q3 		$684K Buy
+5,787
New +$878K 0.05% 369

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Advisor Partners II's MRNA Position: Q3 2023 in Review

Advisor Partners II reduced its Moderna (MRNA) stake by 13% in Q3 2023, selling an estimated $104K and leaving 6,111 shares worth $631K. The position accounts for 0.03% of the portfolio, ranked #625.

Advisor Partners II first reported a position in MRNA in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.89M in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Advisor Partners II held 6,111 shares of Moderna worth $631K as of Q3 2023.
  • Advisor Partners II sold 930 Moderna shares in Q3 2023, an estimated $104K.
  • Moderna made up 0.03% of Advisor Partners II's portfolio in Q3 2023, its #625 holding.
  • Advisor Partners II first reported a position in Moderna in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Moderna position peaked at $1.89M in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.